Literature DB >> 11447210

Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.

I K Santos1, C H Costa, H Krieger, M F Feitosa, D Zurakowski, B Fardin, R B Gomes, D L Weiner, D A Harn, R A Ezekowitz, J E Epstein.   

Abstract

Levels of the serum opsonin mannan-binding lectin (MBL) were directly correlated with the probability of developing visceral leishmaniasis. Monocytes infected with MBL-opsonized Leishmania chagasi promastigotes secreted higher levels of tumor necrosis factor alpha and interleukin-6 than cells infected with nonopsonized parasites. Our findings indicate that MBL can modulate the clinical outcome of infection with L. chagasi and the function of infected macrophages.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11447210      PMCID： PMC98624          DOI： 10.1128/IAI.69.8.5212-5215.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  32 in total

1.  [Visceral leishmaniasis epidemic in the State of Piauí, Brazil, 1980-1986].

Authors:  C H Costa; H F Pereira; M V Araújo
Journal:  Rev Saude Publica       Date:  1990-10       Impact factor: 2.106

Review 2.  The collectins in innate immunity.

Authors:  J Epstein; Q Eichbaum; S Sheriff; R A Ezekowitz
Journal:  Curr Opin Immunol       Date:  1996-02       Impact factor: 7.486

Review 3.  Innate immunity: impact on the adaptive immune response.

Authors:  R Medzhitov; C A Janeway
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

4.  Dual role of mannan-binding protein in infections: another case of heterosis?

Authors:  P Garred; M Harboe; T Oettinger; C Koch; A Svejgaard
Journal:  Eur J Immunogenet       Date:  1994-04

5.  Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype.

Authors:  R J Lipscombe; M Sumiya; J A Summerfield; M W Turner
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

6.  Interleukin 6 during active visceral leishmaniasis and after treatment.

Authors:  T van der Poll; E E Zijlstra; M Mevissen
Journal:  Clin Immunol Immunopathol       Date:  1995-10

7.  Leishmaniasis and AIDS co-infection: the Spanish example.

Authors:  J Alvar
Journal:  Parasitol Today       Date:  1994-04

8.  IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.

Authors:  D E Hatzigeorgiou; S He; J Sobel; K H Grabstein; A Hafner; J L Ho
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

9.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein.

Authors:  H O Madsen; P Garred; S Thiel; J A Kurtzhals; L U Lamm; L P Ryder; A Svejgaard
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

10.  Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells.

Authors:  M Rincón; J Anguita; T Nakamura; E Fikrig; R A Flavell
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307
View more
  38 in total

Review 1.  Mannan-binding lectin in asthma and allergy.

Authors:  Savneet Kaur; Steffen Thiel; P Usha Sarma; Taruna Madan
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

2.  Mannose binding lectin genotypes influence recovery from hepatitis B virus infection.

Authors:  Chloe L Thio; Timothy Mosbruger; Jacquie Astemborski; Spencer Greer; Gregory D Kirk; Stephen J O'Brien; David L Thomas
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Human serum mannose-binding lectin senses wall teichoic acid Glycopolymer of Staphylococcus aureus, which is restricted in infancy.

Authors:  Keun-Hwa Park; Kenji Kurokawa; Lili Zheng; Dong-Jun Jung; Koichiro Tateishi; Jun-O Jin; Nam-Chul Ha; Hee Jung Kang; Misao Matsushita; Jong-Young Kwak; Kazue Takahashi; Bok Luel Lee
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

4.  Mannose-Binding Lectin Levels Could Predict Prognosis in IgA Nephropathy.

Authors:  Wei-Yi Guo; Li Zhu; Si-Jun Meng; Su-Fang Shi; Li-Jun Liu; Ji-Cheng Lv; Hong Zhang
Journal:  J Am Soc Nephrol       Date:  2017-07-11       Impact factor: 10.121

5.  Functional variations in MBL2 gene are associated with cutaneous leishmaniasis in the Amazonas state of Brazil.

Authors:  F J de Araujo; T G Mesquita; L D O da Silva; S A de Almeida; W de S Vital; A Chrusciak-Talhari; J A de O Guerra; S Talhari; R Ramasawmy
Journal:  Genes Immun       Date:  2015-03-12       Impact factor: 2.676

Review 6.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

7.  Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes.

Authors:  Peter Garred; Morten A Nielsen; Jørgen A L Kurtzhals; Rajneesh Malhotra; Hans O Madsen; Bamenla Q Goka; Bartholomew D Akanmori; Robert B Sim; Lars Hviid
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.

Authors:  Henry W Murray
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

9.  Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL.

Authors:  S Kaur; V K Gupta; A Shah; S Thiel; P U Sarma; T Madan
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

10.  Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy.

Authors:  M L Alves Pedroso; A B W Boldt; L Pereira-Ferrari; R Steffensen; E Strauss; J C Jensenius; S O Ioshii; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.